Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1990 1
1991 1
1997 1
1998 2
2001 1
2002 2
2008 1
2009 1
2011 1
2012 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Thrombosis and thrombolysis in unstable angina.
Brochier ML, Raynaud P, Rioux P, Charbonnier B, Desveaux B, Pacouret G. Brochier ML, et al. Among authors: charbonnier b. Am J Cardiol. 1991 Sep 3;68(7):105B-109B. doi: 10.1016/0002-9149(91)90392-x. Am J Cardiol. 1991. PMID: 1909836 Review.
Clinical or angiographic improvement are not always in correlation and until now do not seem able to prevent short-term recurrences or the need for revascularization procedures....
Clinical or angiographic improvement are not always in correlation and until now do not seem able to prevent short-term recurrences o …
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up.
Bonnefoy E, Steg PG, Boutitie F, Dubien PY, Lapostolle F, Roncalli J, Dissait F, Vanzetto G, Leizorowicz A, Kirkorian G; CAPTIM Investigators; Mercier C, McFadden EP, Touboul P. Bonnefoy E, et al. Eur Heart J. 2009 Jul;30(13):1598-606. doi: 10.1093/eurheartj/ehp156. Epub 2009 May 8. Eur Heart J. 2009. PMID: 19429632 Clinical Trial.
Patients were randomized to either a primary angioplasty (n = 421) or a pre-hospital fibrinolysis (rt-PA) with immediate transfer to a centre with interventional facilities (n = 419). Long-term follow-up was obtained in blinded fashion from 795 patients (94.6%). ...
Patients were randomized to either a primary angioplasty (n = 421) or a pre-hospital fibrinolysis (rt-PA) with immediate transfer to a centr …
Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.
Charbonnier BA, Fiessinger JN, Banga JD, Wenzel E, d'Azemar P, Sagnard L. Charbonnier BA, et al. Thromb Haemost. 1998 May;79(5):897-901. Thromb Haemost. 1998. PMID: 9609216 Clinical Trial.
BACKGROUND: Clinical trials have been performed to compare with standard heparin a once or a twice daily regimen of low-molecular-weight heparin but no direct comparison has been done between these two low-molecular-weight heparin regimens in terms of efficacy and safety with a l …
BACKGROUND: Clinical trials have been performed to compare with standard heparin a once or a twice daily regimen of low-molecular-weight hep …
Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial.
Steering Committee. Steering Committee. Am Heart J. 2012 Jan;163(1):33-38.e1. doi: 10.1016/j.ahj.2011.10.003. Am Heart J. 2012. PMID: 22172434 Clinical Trial.
Thrombolysis rapidly reverses RV pressure overload in PE, but it remains unclear whether it may improve the early and long-term clinical outcome of selected normotensive patients. DESIGN: The Pulmonary EmbolIsm THrOmbolysis (PEITHO) trial is a prospective, multicenter, int …
Thrombolysis rapidly reverses RV pressure overload in PE, but it remains unclear whether it may improve the early and long-term clini …
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE; Cassiopea Investigators. Büller HR, et al. Lancet. 2012 Jan 14;379(9811):123-9. doi: 10.1016/S0140-6736(11)61505-5. Epub 2011 Nov 28. Lancet. 2012. PMID: 22130488 Clinical Trial.
INTERPRETATION: Idrabiotaparinux could provide an attractive alternative to warfarin for the long-term treatment of pulmonary embolism, and seems to be associated with reduced bleeding. ...
INTERPRETATION: Idrabiotaparinux could provide an attractive alternative to warfarin for the long-term treatment of pulmonary embolis …
Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction.
Weber S, Vaur L, Ounnoughene Z, Schwob J, Dubroca I, Normand J, Etienne S, Charbonnier B. Weber S, et al. Among authors: charbonnier b. Am Heart J. 2002 Feb;143(2):313-8. doi: 10.1067/mhj.2002.120150. Am Heart J. 2002. PMID: 11835037 Clinical Trial.
OBJECTIVE: Our purpose was to compare the blood pressure response to short-term treatment with captopril or trandolapril in patients with left ventricular (LV) dysfunction after acute myocardial infarction (AMI). ...CONCLUSION: Because of differences in initial blood press …
OBJECTIVE: Our purpose was to compare the blood pressure response to short-term treatment with captopril or trandolapril in patients …
Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
Davy JM, Herold M, Hoglund C, Timmermans A, Alings A, Radzik D, Van Kempen L; ERATO Study Investigators. Davy JM, et al. Am Heart J. 2008 Sep;156(3):527.e1-9. doi: 10.1016/j.ahj.2008.06.010. Am Heart J. 2008. PMID: 18760136 Clinical Trial.
Dronedarone was well tolerated with no evidence of organ toxicities or proarrhythmias in this short-term study....
Dronedarone was well tolerated with no evidence of organ toxicities or proarrhythmias in this short-term study....
Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure.
Forissier JF, Vernochet P, Bertrand P, Charbonnier B, Monpère C. Forissier JF, et al. Among authors: charbonnier b. Eur J Heart Fail. 2001 Jun;3(3):335-42. doi: 10.1016/s1388-9842(00)00152-5. Eur J Heart Fail. 2001. PMID: 11378005 Free article.
AIMS: To evaluate prospectively the impact of carvedilol on a short-term physical training program in stable patients with moderate chronic heart failure (CHF), and to analyze parameters predictive of improvement after training. ...CONCLUSION: Addition of carvedilol did no …
AIMS: To evaluate prospectively the impact of carvedilol on a short-term physical training program in stable patients with moderate c …
[Paroxysmal sinoatrial tachycardia. Apropos of 44 cases].
Fauchier JP, Latour F, Neel C, Charbonnier B, Brochier M. Fauchier JP, et al. Among authors: charbonnier b. Arch Mal Coeur Vaiss. 1980 Feb;73(2):165-75. Arch Mal Coeur Vaiss. 1980. PMID: 6769406 French.
They can be triggered and terminated by one (or two) atrial stimuli, and reduced by carotid sinus massage but relapse in the short term. They often alternate with a disturbance of atrial excitability in patients who also have binodal disease. ...
They can be triggered and terminated by one (or two) atrial stimuli, and reduced by carotid sinus massage but relapse in the short term …
[Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].
Charbonnier B, Monpère C, Desveaux B, Cosnay P, Fauchier JP, Brochier M. Charbonnier B, et al. Ann Cardiol Angeiol (Paris). 1984 May-Jun;33(4):233-7. Ann Cardiol Angeiol (Paris). 1984. PMID: 6087714 French.
Side effects which resolved after changing the dosage were seen in one third of cases: renal failure (4 cases), hypotension (2 cases), hyperkalaemia (1 case). In the long term, 6 patients (2.6%) died after a mean delay of 15.6 +/- 5.3 months....
Side effects which resolved after changing the dosage were seen in one third of cases: renal failure (4 cases), hypotension (2 cases), hyper …
14 results